270257-39-1 Usage
Description
(1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate is a complex organic chemical compound characterized by the presence of a benzyl group, a cyanopiperidine ring, a methyl group, and a benzenesulfonate moiety. Its intricate molecular structure suggests potential for interactions with biological targets, which may be harnessed in medicinal chemistry and drug development.
Uses
Used in Medicinal Chemistry:
(1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate is used as a potential candidate in medicinal chemistry for its structural features that may allow it to interact with specific biological targets, contributing to the development of new therapeutic agents.
Used in Drug Development:
In the field of drug development, (1-Benzyl-4-cyanopiperidin-4-yl)methyl 4-methylbenzenesulfonate is utilized as a compound of interest for further research and experimentation. Its unique structure may offer novel mechanisms of action or selectivity in targeting disease-related pathways.
Check Digit Verification of cas no
The CAS Registry Mumber 270257-39-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,0,2,5 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 270257-39:
(8*2)+(7*7)+(6*0)+(5*2)+(4*5)+(3*7)+(2*3)+(1*9)=131
131 % 10 = 1
So 270257-39-1 is a valid CAS Registry Number.
InChI:InChI=1/C21H24N2O3S/c1-18-7-9-20(10-8-18)27(24,25)26-17-21(16-22)11-13-23(14-12-21)15-19-5-3-2-4-6-19/h2-10H,11-15,17H2,1H3
270257-39-1Relevant articles and documents
NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES
-
Page/Page column 91, (2008/06/13)
The invention provides compounds of general formula (I) wherein A, B, p, w, x, y, and z are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.